{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:53:13Z","timestamp":1792803193838,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303246"],"award-info":[{"award-number":["82303246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ50493"],"award-info":[{"award-number":["2025JJ50493"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2026JJ81943"],"award-info":[{"award-number":["2026JJ81943"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neo.2026.101298","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:33:24Z","timestamp":1774028004000},"page":"101298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesis"],"prefix":"10.1016","volume":"75","author":[{"given":"Xun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2026.101298_bib0001","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.neo.2026.101298_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216585","article-title":"CMTM6 promotes hepatocellular carcinoma progression through stabilizing \u03b2-catenin","volume":"583","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101298_bib0003","first-page":"0184","article-title":"NOP2-mediated m5C Modification of c-Myc in an EIF3A-dependent manner to reprogram glucose metabolism and promote hepatocellular carcinoma progression","volume":"6","author":"Zhang","year":"2023","journal-title":"Research (Wash. D C)"},{"key":"10.1016\/j.neo.2026.101298_bib0004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: a review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg."},{"key":"10.1016\/j.neo.2026.101298_bib0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/CM9.0000000000002641","article-title":"Precision diagnosis of hepatocellular carcinoma","volume":"136","author":"Wang","year":"2023","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.neo.2026.101298_bib0006","first-page":"225","article-title":"A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma","volume":"12","author":"Wang","year":"2024","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.neo.2026.101298_bib0007","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.neo.2026.101298_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217061","article-title":"Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies","volume":"597","author":"Cao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101298_bib0009","first-page":"0036","article-title":"Comprehensive metabolic profiling and genome-wide analysis reveal therapeutic modalities for hepatocellular carcinoma","volume":"6","author":"Qi","year":"2023","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.neo.2026.101298_bib0010","article-title":"Targeting endothelial cell-specific molecule 1 protein in cancer: a promising therapeutic approach","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2026.101298_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112461","article-title":"Lactate drives the ESM1-SCD1 axis to inhibit the antitumor CD8(+) T-cell response by activating the Wnt\/\u03b2-catenin pathway in ovarian cancer cells and inducing cisplatin resistance","volume":"137","author":"Fan","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neo.2026.101298_bib0012","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1038\/s41598-024-82400-z","article-title":"ESM1 promote proliferation, invasion and angiogenesis via Akt\/mTOR and Ras pathway in kidney renal clear cell carcinoma","volume":"15","author":"Luo","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2026.101298_bib0013","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2174\/1871520619666190705151542","article-title":"ESM-1: a novel tumor biomaker and its research advances","volume":"19","author":"Li","year":"2019","journal-title":"AntiCancer Agents Med. Chem."},{"key":"10.1016\/j.neo.2026.101298_bib0014","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","article-title":"ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neo.2026.101298_bib0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12967-023-04819-8","article-title":"ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2\/STAT3 pathway and interacting with ESM1","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neo.2026.101298_bib0016","article-title":"The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells","volume":"10","author":"Feng","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.neo.2026.101298_bib0017","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12943-024-02195-5","article-title":"ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis","volume":"23","author":"Mo","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neo.2026.101298_bib0018","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/dna.2024.0022","article-title":"ANGPTL4 stabilizes bone morphogenetic protein 7 through deubiquitination and promotes HCC proliferation via the SMAD\/MAPK pathway","volume":"43","author":"Bai","year":"2024","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.neo.2026.101298_bib0019","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1476-4598-13-196","article-title":"Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma","volume":"13","author":"Ng","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neo.2026.101298_bib0020","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1158\/1078-0432.CCR-19-0859","article-title":"ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma","volume":"25","author":"Calderaro","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101298_bib0021","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/mc.23794","article-title":"Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell-specific molecule 1 expression","volume":"63","author":"Zhao","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.neo.2026.101298_bib0022","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1515\/jtim-2024-0035","article-title":"Artificial intelligence for disease X: progress and challenges","volume":"12","author":"Chen","year":"2024","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.neo.2026.101298_bib0023","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1515\/jtim-2024-0023","article-title":"Prognostic prediction of m6A and ferroptosis-associated lncRNAs in liver hepatocellular carcinoma","volume":"12","author":"Gao","year":"2024","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.neo.2026.101298_bib0024","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2478\/jtim-2024-0009","article-title":"Machine learning-based phenogroups and prediction model in patients with functional gastrointestinal disorders to reveal distinct disease subsets associated with gas production","volume":"12","author":"Zhu","year":"2024","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.neo.2026.101298_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2478\/jtim-2023-0089","article-title":"A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients","volume":"11","author":"Liu","year":"2023","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.neo.2026.101298_bib0026","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7150\/ijbs.66839","article-title":"Validation of ESM1 related to ovarian cancer and the biological function and prognostic significance","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neo.2026.101298_bib0027","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s10020-024-00995-5","article-title":"Triolein alleviates ischemic stroke brain injury by regulating autophagy and inflammation through the AKT\/mTOR signaling pathway","volume":"30","author":"Wang","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.neo.2026.101298_bib0028","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41698-024-00625-7","article-title":"B cell lymphoma 6 promotes hepatocellular carcinoma progression by inhibiting tumor infiltrating CD4(+)T cell cytotoxicity through ESM1","volume":"8","author":"Li","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.neo.2026.101298_bib0029","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imm.13650","article-title":"Deficiency of angiopoietin-like 4 enhances CD8(+) T cell bioactivity via metabolic reprogramming for impairing tumour progression","volume":"170","author":"Ding","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.neo.2026.101298_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13046-025-03282-1","article-title":"Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO\/m (6)A\/ANGPTL4\/integrin axis in triple-negative breast cancer","volume":"44","author":"Zhang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101298_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1026954","article-title":"Major pathways involved in macrophage polarization in cancer","volume":"13","author":"Kerneur","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2026.101298_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103757","article-title":"CD4(+)CD8(+) double-positive T cells in immune disorders and cancer: prospects and hurdles in immunotherapy","volume":"24","author":"Alam","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.neo.2026.101298_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2026.116927","article-title":"ESM1 SUMOylation mediates bevacizumab resistance in ovarian cancer through ITGB1-FAK-driven angiogenesis","volume":"45","author":"Ran","year":"2026","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2026.101298_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1454161","article-title":"The role of metabolic reprogramming in liver cancer and its clinical perspectives","volume":"14","author":"Lu","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2026.101298_bib0035","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/HEP.0000000000000962","article-title":"Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC","volume":"81","author":"Liu","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.neo.2026.101298_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217006","article-title":"CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer","volume":"595","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101298_bib0037","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.ymthe.2022.03.015","article-title":"An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming","volume":"30","author":"Liu","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neo.2026.101298_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217084","article-title":"Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression","volume":"597","author":"Tsui","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101298_bib0039","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41419-024-06929-7","article-title":"Deficiency of SIAH1 promotes the formation of filopodia by increasing the accumulation of FASN in liver cancer","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.neo.2026.101298_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100660","article-title":"Fatty acid synthase inhibitor cerulenin hinders liver cancer stem cell properties through FASN\/APP axis as novel therapeutic strategies","volume":"65","author":"Chen","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neo.2026.101298_bib0041","article-title":"Transcriptional regulation of De Novo lipogenesis by SIX1 in liver cancer cells","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.neo.2026.101298_bib0042","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-024-06463-6","article-title":"The implications of FASN in immune cell biology and related diseases","volume":"15","author":"Xiao","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neo.2026.101298_bib0043","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S2468-1253(24)00246-2","article-title":"Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Loomba","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.neo.2026.101298_bib0044","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/bjc.1992.216","article-title":"Lipid metabolism in cancer cachexia","volume":"66","author":"Mulligan","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neo.2026.101298_bib0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1124\/jpet.114.222281","article-title":"The novel anticancer drug hydroxytriolein inhibits lung cancer cell proliferation via a protein Kinase C\u03b1- and extracellular signal-regulated Kinase 1\/2-dependent mechanism","volume":"354","author":"Guardiola-Serrano","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neo.2026.101298_bib0046","first-page":"185","article-title":"NF-\u03baB in liver cancer: the plot thickens","volume":"349","author":"Finkin","year":"2011","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.neo.2026.101298_bib0047","first-page":"12","article-title":"ESM-1 overexpression is involved in increased tumorigenesis of radiotherapy-resistant breast cancer cells","author":"Jin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neo.2026.101298_bib0048","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cellsig.2012.06.004","article-title":"ESM-1 regulates cell growth and metastatic process through activation of NF-\u03baB in colorectal cancer","volume":"24","author":"Kang","year":"2012","journal-title":"Cell Signal."},{"key":"10.1016\/j.neo.2026.101298_bib0049","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00726-010-0729-6","article-title":"ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma","volume":"40","author":"Kang","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.neo.2026.101298_bib0050","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.7314\/APJCP.2015.16.18.8579","article-title":"Significance of tissue expression and serum levels of angiopoietin-like protein 4 in breast cancer progression: link to NF-\u03baB \/P65 activity and pro-inflammatory cytokines","volume":"16","author":"Shafik","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.neo.2026.101298_bib0051","doi-asserted-by":"crossref","DOI":"10.1080\/16546628.2017.1338918","article-title":"Angiopoietin-like protein 4 potentiates DATS-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; involvement of G (2)\/M-phase cell cycle arrest, signaling pathways, and transcription factors-mediated MMP-9 expression","volume":"61","author":"Shin","year":"2017","journal-title":"Food Nutr. Res."},{"key":"10.1016\/j.neo.2026.101298_bib0052","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3892\/or.2020.7647","article-title":"Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4","volume":"44","author":"Zhou","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.neo.2026.101298_bib0053","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49486-2","article-title":"Fatty acid inhibition sensitizes androgen-dependent and -independent prostate cancer to radiotherapy via FASN\/NF-\u03baB pathway","volume":"9","author":"Chuang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2026.101298_bib0054","first-page":"13","article-title":"Epigenetic silencing of miR-33b promotes peritoneal metastases of ovarian cancer by modulating the TAK1\/FASN\/CPT1A\/NF-\u03baB axis","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neo.2026.101298_bib0055","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41419-025-07571-7","article-title":"IGF2BP3\/ESM1\/KLF10\/BECN1 positive feedback loop: a novel therapeutic target in ovarian cancer via lipid metabolism reprogramming","volume":"16","author":"Gao","year":"2025","journal-title":"Cell Death & Dis."},{"key":"10.1016\/j.neo.2026.101298_bib0056","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12672-025-02113-1","article-title":"ESM1 suppresses LncRNA GAS5\/miR-23a-3p\/PTEN axis to promote the cisplatin-chemotherapy resistance of ovarian cancer cells via activating the PI3K\/AKT pathway","volume":"16","author":"Li","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.neo.2026.101298_bib0057","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fimmu.2019.00651","article-title":"Targeting tumor vascular CD99 inhibits tumor growth","volume":"10","author":"Huijbers","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2026.101298_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101759","article-title":"Overexpression of CD99 is associated with tumor adaptiveness and indicates the tumor recurrence and therapeutic responses in gliomas","volume":"37","author":"Shang","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.neo.2026.101298_bib0059","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1038\/s41467-025-63184-w","article-title":"CD99-mediated immunological synapse formation potentiates CAR-T cell function","volume":"16","author":"Nam","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101298_bib0060","first-page":"14","article-title":"Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and antibody for targeting T cell malignancies","author":"Takheaw","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.neo.2026.101298_bib0061","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s12672-025-02281-0","article-title":"Evaluating the immune effector functions induced by humanized anti-CD99 antibody in eliminating T lymphoblastic leukemia\/lymphoma cells","volume":"16","author":"Kotemul","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.neo.2026.101298_bib0062","doi-asserted-by":"crossref","first-page":"96","DOI":"10.37349\/etat.2024.00207","article-title":"CD99 tumor associated antigen is a potential target for antibody therapy of T-cell acute lymphoblastic leukemia","volume":"5","author":"Kotemul","year":"2024","journal-title":"Explor. Target. Antitumor. Ther."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:06:22Z","timestamp":1776193582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"alternative-id":["S1476558626000278"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101298","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesis","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101298"}}